Fouad YM - Search Results

1

Fouad YM, Yehia R. Fouad YM, et al. World J Hepatol. 2014 Jan 27;6(1):41-54. doi: 10.4254/wjh.v6.i1.41. World J Hepatol. 2014. PMID: 24653793 Free PMC article. Review.

2

Relation between Cytokine Levels and Pulmonary Dysfunction in COVID-19 Patients: A Case-Control Study.

El Kazafy SA, Fouad YM, Said AF, Assal HH, Ahmed AE, El Askary A, Ali TM, Ahmed OM. El Kazafy SA, et al. Among authors: fouad ym. J Pers Med. 2022 Dec 23;13(1):34. doi: 10.3390/jpm13010034. J Pers Med. 2022. PMID: 36675695 Free PMC article.

3

Correlations between Cytokine Levels, Liver Function Markers, and Neuropilin-1 Expression in Patients with COVID-19.

El Kazafy SA, Fouad YM, Said AF, Assal HH, Ali TM, Ahmed AE, Elesawy BH, Ahmed OM. El Kazafy SA, et al. Among authors: fouad ym. Vaccines (Basel). 2022 Sep 29;10(10):1636. doi: 10.3390/vaccines10101636. Vaccines (Basel). 2022. PMID: 36298501 Free PMC article.

4

Biomarkers of Barrett's esophagus.

Fouad YM, Mostafa I, Yehia R, El-Khayat H. Fouad YM, et al. World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):450-6. doi: 10.4291/wjgp.v5.i4.450. World J Gastrointest Pathophysiol. 2014. PMID: 25400988 Free PMC article. Review.

5

Metabolic-associated fatty liver disease: New nomenclature and approach with hot debate.

Fouad Y. Fouad Y. World J Hepatol. 2023 Feb 27;15(2):123-128. doi: 10.4254/wjh.v15.i2.123. World J Hepatol. 2023. PMID: 36926229 Free PMC article.

6

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.

Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wai-Sun Wong V, Dufour JF, Schattenberg JM, Kawaguchi T, Arrese M, Valenti L, Shiha G, Tiribelli C, Yki-Järvinen H, Fan JG, Grønbæk H, Yilmaz Y, Cortez-Pinto H, Oliveira CP, Bedossa P, Adams LA, Zheng MH, Fouad Y, Chan WK, Mendez-Sanchez N, Ahn SH, Castera L, Bugianesi E, Ratziu V, George J. Eslam M, et al. J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278004 Free article. Review.

7

The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.

Spearman CW, Desalegn H, Ocama P, Awuku YA, Ojo O, Elsahhar M, Abdo AA, Ndububa DA, Fouad Y, Borodo MM, Ng'wanasayi M, Ally R, Elwakil R. Spearman CW, et al. J Hepatol. 2021 May;74(5):1256-1258. doi: 10.1016/j.jhep.2021.01.015. Epub 2021 Jan 20. J Hepatol. 2021. PMID: 33484771 No abstract available.

8

Capturing patient experience: A qualitative study of change from NAFLD to MAFLD real-time feedback.

Alem SA, Gaber Y, Abdalla M, Said E, Fouad Y. Alem SA, et al. J Hepatol. 2021 May;74(5):1261-1262. doi: 10.1016/j.jhep.2021.01.022. Epub 2021 Jan 23. J Hepatol. 2021. PMID: 33497764 No abstract available.

9

Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists.

Fouad Y, Gomaa A, Semida N, Ghany WA, Attia D. Fouad Y, et al. J Hepatol. 2021 May;74(5):1254-1256. doi: 10.1016/j.jhep.2020.12.035. Epub 2021 Feb 11. J Hepatol. 2021. PMID: 33582129 No abstract available.

10

One not like the other: The weakness of the blood sugar-MAFLD analogy.

Fouad YM, Méndez-Sánchez N, Zheng MH. Fouad YM, et al. J Hepatol. 2022 Feb;76(2):482-484. doi: 10.1016/j.jhep.2021.10.010. Epub 2021 Oct 20. J Hepatol. 2022. PMID: 34678406 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82 results

Search Page